ArticleMedical journal of the Islamic Republic of Iran2025
Peripheral IL-6/IL-17/NF-κB1 and IL-10 Signaling in Children with Autism Spectrum Disorder: Integrative Transcriptomic Analysis and qRT-PCR Validation.
Article in Medical journal of the Islamic Republic of Iran, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autism spectrum disorder (ASD) is associated with immune and inflammatory dysregulation. However, the molecular networks linking peripheral immune signatures to neuroinflammatory processes remain poorly understood. This study aimed to explore inflammation-related molecular pathways in ASD through integrated transcriptomic network analysis and to validate key cytokine genes (IL6, IL10, IL17, NF-κB1) using quantitative real-time polymerase chain reaction (qRT-PCR). Methods: This was an integrative computational-experimental study. We analyzed 4 gene expression Omnibus (GEO) transcriptomic datasets (GSE18123, GSE111176, GSE87847, GSE6575), constructed protein-protein interaction (PPI) networks, and identified inflammation-related modules. Selected inflammatory genes (IL6, IL10, IL17, NF-ΚB1) were validated by qRT-PCR in peripheral blood samples from ASD (n = 15) and healthy controls (n = 5). Statistical analyses were conducted in R. Data normality was assessed using the Shapiro-Wilk test, and normally distributed variables were compared using t-tests. Results: Integration of datasets revealed core differentially expressed genes (DEGs) and a connected PPI network (26 nodes, 88 edges), with hub genes such as PUM1, TRRAP, ILF3, INO80, and PTBP1. Functional enrichment indicated cytokine-mediated signaling, leukocyte activation, and neuroinflammation processes. Network analysis highlighted central regulators linking chromatin remodeling, ribonucleic acid (RNA) processing, and immune signaling. qRT-PCR confirmed dysregulation of IL6 (fold change ≈ 12.8, Conclusion: The findings suggest an IL-6/IL-17/NF-κB1-centric proinflammatory axis and reduced IL-10-mediated regulation in ASD, implicating peripheral immune activation and transcriptional regulators in neuroinflammatory processes. The identified hub genes and pathways may serve as biomarkers and therapeutic targets for an inflammation-associated ASD subtype. Limitations include small qRT-PCR sample size and lack of protein-level validation; future studies should explore longitudinal and multiomics approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.